Measureable Results

We partner with our clients from the start of every project to determine the right mix of measurement.  To measure the success of our programs, we consider the following:

  • Media Impressions
  • Patient/Consumer Reach
  • Direct Touchpoints
  • Indirect Touchpoints
  • Halo Metrics

In short, we look to see how our efforts are influencing your bottom line.

Testimonials

Read what clients are saying about Jones Public Affairs.

Case Studies

Bristol-Myers Squibb

Bristol-Myers Squibb (BMS), a biopharmaceutical company focused on cancer and other hard-to-treat diseases, sought ways to demonstrate its value as an innovative partner to the global advocacy community.  BMS hired Jones Public Affairs to support the global patient advocacy team across multiple oncology accounts, including: Sprycel,® Ixempra,™ and Ipilimumab.

JPA conducted a global assessment—or “mapping”— of patient advocacy groups (PAGs) in key regions and countries for several cancer types, including prostate cancer, multiple myeloma and chronic myelogenous leukemia (CML).  Comprehensive dossiers were prepared, including information about the PAGs’ leadership and best contacts, mission and vision, vital statistics, and funding, as well as recommendations for perspective partnerships.

Using the mapping results, JPA supported BMS in the development of several global advisory board meetings comprised of representatives from advocacy organizations around the world.  These two-day meetings were instrumental in identifying “unmet” patient needs and formulating solutions to address these needs.  With JPA’s assistance, BMS has established a multi-faceted advocacy strategy that supports its disease state messaging in partnership with the patient community.

Melanoma Research Foundation

The Melanoma Research Foundation (MRF) is the largest private, national organization in the United States devoted to melanoma, the most serious form of skin cancer.  Because of the rising incidence of melanoma, MRF sought a public relations agency to raise awareness of the disease, the importance of prevention and early detection, and the need for additional research.

As the agency of record for MRF, Jones Public Affairs works to broaden awareness and reach of the organization and generate greater visibility among key audiences.  The cornerstone of the MRF’s public education campaign is media relations.  A news bureau was established with a dedicated staff member to proactively engage the media about melanoma and the importance of early diagnosis.

Through proactive efforts, JPA has been successful in securing top-tier media interviews with MRF spokespeople.  Reactively, the agency has placed multiple letters-to-the editor, op-eds and official statements.  Recent coverage has included: Newsweek, U.S. News and World Report, and The New York Times.

Partnership for Safe Medicines

The Partnership for Safe Medicines (PSM), a coalition of organizations and individuals that have policies, procedures, or programs to protect consumers from counterfeit or contraband medicines, sought to leverage its collective expertise to establish itself as one of the most creditable resources on the issue of drug safety.

Jones Public Affairs and our online partner, Virilion, developed a strategic program to raise the visibility of the Partnership and generate awareness about the risks and safety issues of counterfeit drugs.  Because “new” news on this issue can be sparse, JPA created a blog featuring original, expert commentary on current drug safety issues.  This content leveraged the impressive credentials and comprehensive expertise of the coalition’s Board of Directors.  The team also implemented several email campaigns to deliver regular updates on drug safety issues to Congressional staff and members of its coalition.  By integrating the content and timing of blog, emails, and PSM’s additional offline communications, the team has extended the reach of key PSM messages across multiple channels.

Web traffic to PSM’s website, SafeMedicines.org, has drastically increased because of email campaigns, blog entries and linking efforts.  In just over six months, PSM’s Google ranking for the term “counterfeit drugs” rose from 80 to number five.  The team has demonstrated is capabilities with rapid response by reaching legislative staffers with “breaking news” about FDA reform and drug safety, while raising the profile of PSM.